JOP20210063A1 - مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها - Google Patents

مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها

Info

Publication number
JOP20210063A1
JOP20210063A1 JOP/2021/0063A JOP20210063A JOP20210063A1 JO P20210063 A1 JOP20210063 A1 JO P20210063A1 JO P20210063 A JOP20210063 A JO P20210063A JO P20210063 A1 JOP20210063 A1 JO P20210063A1
Authority
JO
Jordan
Prior art keywords
pyrimidonyl
preparation
pharmaceutical compositions
compositions containing
new amino
Prior art date
Application number
JOP/2021/0063A
Other languages
English (en)
Inventor
Lisa Ivanschitz
Olivier Geneste
Didier Demarles
Péter Spr?Nitz
Tibor So?S
Attila Vasas
Andrea Fiumana
Andr?S Kotschy
?Rp?D Kiss
Alba Macias
James Brooke Murray
Bal?Zs Moln?R
Krist?F Hegedus
Csaba Weber
Original Assignee
Servier Lab
Vernalis Randd Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis Randd Ltd filed Critical Servier Lab
Publication of JOP20210063A1 publication Critical patent/JOP20210063A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

غير متوفر حاليا
JOP/2021/0063A 2018-10-19 2019-10-18 مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها JOP20210063A1 (ar)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306377 2018-10-19
EP19305936 2019-07-12
PCT/EP2019/078318 WO2020079205A1 (en) 2018-10-19 2019-10-18 New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
JOP20210063A1 true JOP20210063A1 (ar) 2023-01-30

Family

ID=68234009

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2021/0063A JOP20210063A1 (ar) 2018-10-19 2019-10-18 مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها

Country Status (24)

Country Link
US (1) US20210355106A1 (ar)
EP (1) EP3866930A1 (ar)
JP (1) JP2022505122A (ar)
KR (1) KR20210081371A (ar)
CN (1) CN113038990A (ar)
AU (1) AU2019360391A1 (ar)
BR (1) BR112021006714A2 (ar)
CA (1) CA3116089A1 (ar)
CL (1) CL2021000973A1 (ar)
CO (1) CO2021004553A2 (ar)
CR (1) CR20210173A (ar)
DO (1) DOP2021000063A (ar)
EC (1) ECSP21024078A (ar)
IL (1) IL282218A (ar)
JO (1) JOP20210063A1 (ar)
MA (1) MA53900A (ar)
MX (1) MX2021004379A (ar)
NI (1) NI202100024A (ar)
PE (1) PE20211649A1 (ar)
PH (1) PH12021550788A1 (ar)
SG (1) SG11202103279RA (ar)
TW (1) TW202028188A (ar)
UY (1) UY38423A (ar)
WO (1) WO2020079205A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506917A (ja) 2019-12-20 2023-02-20 バイエル・アクチエンゲゼルシヤフト 置換チオフェンカルボキサミド、チオフェンカルボン酸およびその誘導体
CN114507163A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA123793C2 (uk) * 2016-06-10 2021-06-02 Ле Лаборатуар Сервьє Нові (гетеро)арил-заміщені похідні піперидинілу, спосіб їхнього одержання та фармацевтичні композиції, що їх містять
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB201617758D0 (en) * 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds

Also Published As

Publication number Publication date
US20210355106A1 (en) 2021-11-18
PH12021550788A1 (en) 2021-10-18
IL282218A (en) 2021-05-31
CR20210173A (es) 2021-05-11
MA53900A (fr) 2022-01-26
JP2022505122A (ja) 2022-01-14
CA3116089A1 (en) 2020-04-23
SG11202103279RA (en) 2021-04-29
DOP2021000063A (es) 2021-08-31
TW202028188A (zh) 2020-08-01
CO2021004553A2 (es) 2021-04-30
EP3866930A1 (en) 2021-08-25
AU2019360391A1 (en) 2021-05-13
CL2021000973A1 (es) 2021-11-19
BR112021006714A2 (pt) 2021-07-27
MX2021004379A (es) 2021-06-04
KR20210081371A (ko) 2021-07-01
NI202100024A (es) 2021-08-24
ECSP21024078A (es) 2021-05-31
WO2020079205A1 (en) 2020-04-23
UY38423A (es) 2021-02-26
CN113038990A (zh) 2021-06-25
PE20211649A1 (es) 2021-08-24

Similar Documents

Publication Publication Date Title
SA518392049B1 (ar) مشتقات أمونيوم جديدة، عملية لتحضيرها وتركيبات صيدلانية تحتوي عليها
PH12018502515B1 (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
PH12018502516B1 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
PH12017502315B1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
SA517390586B1 (ar) مشتقات حمض هيدروكسي جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
PH12017502246B1 (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
SA517390583B1 (ar) مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
PH12020550448A1 (en) Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same
PH12021550788A1 (en) New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2020014327A (es) Nuevos derivados de amino-pirimidonilo un proceso para su preparacion y composiciones farmaceuticas que los contienen.